XPONANCE, INC. - CONMED CORP ownership

CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 253 filers reported holding CONMED CORP in Q2 2021. The put-call ratio across all filers is 8.16 and the average weighting 0.1%.

Quarter-by-quarter ownership
XPONANCE, INC. ownership history of CONMED CORP
ValueSharesWeighting
Q4 2023$203,908
-16.6%
1,862
+3.4%
0.00%
-33.3%
Q2 2023$244,602
-10.4%
1,800
-2.4%
0.00%
-40.0%
Q1 2022$273,000
-3.2%
1,844
-10.1%
0.01%0.0%
Q2 2021$282,0002,0510.01%
Other shareholders
CONMED CORP shareholders Q2 2021
NameSharesValueWeighting ↓
Hood River Capital Management LLC 448,126$38,346,0001.80%
HealthCor Management, L.P. 455,190$38,951,0001.51%
Champlain Investment Partners, LLC 1,452,360$124,278,0001.04%
J. Goldman & Co LP 162,771$13,928,0000.96%
Granahan Investment Management 189,925$16,252,0000.80%
PURA VIDA INVESTMENTS, LLC 50,000$4,279,0000.65%
OAK RIDGE INVESTMENTS LLC 102,797$8,797,0000.61%
LANDSCAPE CAPITAL MANAGEMENT, L.L.C. 78,722$6,736,0000.54%
MOODY ALDRICH PARTNERS LLC 23,834$2,039,0000.52%
361 CAPITAL LLC 30,901$2,644,0000.47%
View complete list of CONMED CORP shareholders